top of page
We enable
continuous observability of immune response
as a biological process
through longitudinal measurement of the system-level metabolomic response to immune activation, at the point of care and beyond.
A New Category of Clinical Data
Immune response is a central biological process across infection, cancer, autoimmune disease, metabolic disorders, and recovery after intervention. Yet it remains difficult to observe as a continuous trajectory.
Immune activity is reflected not by a single biomarker, but by coordinated changes across multiple metabolites associated with immune activation.
Longitudinal immunometabolic measurement enables structured observation of immune-response dynamics over time, introducing a new category of clinical data: trajectory-level physiological signals.
An Unoccupied Measurement Layer
Existing technologies provide either predefined biomarkers or broad molecular profiling in centralized laboratory environments.
Biomarker panels are hypothesis-driven and limited in their ability to capture system-level dynamics.
Centralized -omics approaches provide rich molecular data but are not compatible with repeated longitudinal deployment outside specialized laboratories.
An important measurement layer remains insufficiently addressed: structured system-level signals reflecting immune-response dynamics, compatible with non-invasive repeated sampling and deployment at the point of care.
Clinical Relevance
Immune-response dynamics influence disease progression across multiple clinical domains, including:
• infectious diseases;
• autoimmune and inflammatory conditions;
• oncology treatment response;
• metabolic diseases involving chronic; immune activation;
• transplantation and post-surgical recovery.
Our initial observations demonstrate reproducible structured immune-response trajectories in infectious diseases and acute inflammatory conditions.
Longitudinal Immunometabolic Trajectories
The platform captures coordinated metabolic variation associated with immune activation, enabling observation of:
• early immune activation dynamics;
• treatment-response trajectories;
• recovery processes beyond symptomatic resolution;
• deviations from expected response patterns.
Trajectory-level signals provide functional insight into how immune response evolves over time.
Non-invasive Longitudinal Measurement Outside Centralized Laboratories
Urine-based metabolomic analysis enables passive sampling compatible with repeated use without patient burden.
The platform architecture supports longitudinal acquisition of structured biological time-series outside centralized laboratory environments, including point-of-care and distributed clinical settings.
Toward Trajectory-Informed Medicine
Structured longitudinal biological signals enable quantitative analysis of disease dynamics over time, supporting:
• modeling of disease trajectories
• therapy-response characterization
• identification of response subtypes
• AI-supported analysis of immune-response dynamics
Longitudinal immunometabolic measurement enables observation of immune response as an evolving biological process rather than a sequence of isolated measurements.
Anchor 1
Become a Pilot Partner
We collaborate with clinical research centers exploring longitudinal measurement of immune-response dynamics in translational and clinical research contexts.
Email: team@hiddenmotif.com
bottom of page